.png?width=139&height=120&name=Re5_Logo_Version1_Color%20(2).png){kind=logo}
Other research: PCS & MCS
Research with Re5 technology (T-PEMF) has shown promising results in the treatment of post-concussion syndrome (PCS) and Multiple Chemical Sensitivity (MCS);
Research published in Acta Neurologica Scandinavica has shown that Re5 technology may offer a new treatment pathway for people with PCS, with high compliance and symptom relief.
Another study indicates the potential benefits of Re5 technology in the treatment of MCS, a condition that until now has been difficult to address effectively.
These discoveries emphasize the importance of further research to expand our treatment options and improve the quality of life for patients affected by these complex conditions.
See the research below.
Other research with the Re5 technology
%20as%20post%E2%80%90concussion%20syndrome%20treatment.jpg){kind=spacer}
Transcranial low-frequency pulsating electromagnetic fields
(T-PEMF) as post-concussion syndrome treatment (2020)
Transcranial pulsed electromagnetic fields for multiple chemical sensitivity: study protocol for a randomized, double-blind, placebo-controlled trial (2013)